Clinical Trial

Maternal Characteristics Associated With Child Growth and Adiposity

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to investigate the concentrations of leptin, insulin, liver expressed antimicrobial peptide 2 (LEAP2), and cortisol in plasma and breast milk and their relationship with eating behavior, growth, adiposity and with the levels of these hormones in infants, comparing mothers with normal weight and with pre-pregnancy overweight/obesity. The main question\[s\] it aims to answer are: * Are maternal hormones associated with child growth and adiposity * Are maternal hormone receptors associated with child growth and adiposity * Are infant hormones and their receptors associated with child growth and adiposity * Are maternal and infant hormones and their receptors associated with child eating behavior Participants will provide milk and blood samples. Researchers will compare mothers with normal weight and with pre-pregnancy overweight/obesity to see if there are differences in child growth and adiposity .
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-03-22; most recent amendment 2025-12-19.
Trial Details
NCT Number NCT05798676
Lead Sponsor Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri
Conditions Obesity, Obesity, Infant
Enrollment 130 participants
Start Date 2019-05-02
Primary Completion 2028-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2025-12-26